Energy News / Shareholders Foundation, Inc.

NASDAQ:XENT Long-Term Shareholder Notice: Investigation of Potential Wrongdoing at Intersect ENT Inc

Via: ReleaseWire

Updated 10:14 AM CDT, Tue, July 23,2019

An investigation on behalf of current long term investors in Intersect ENT Inc (NASDAQ: XENT) shares over possible breaches of fiduciary duty by certain officers and directors was announced and NASDAQ: XENT stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 07/23/2019 -- An investigation was announced for current long-term investors in shares of Intersect ENT Inc (NASDAQ: XENT) concerning potential breaches of fiduciary duties by certain directors of Intersect ENT Inc.

Investors who are current long term investors in Intersect ENT Inc (NASDAQ: XENT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: XENT stocks follows a lawsuit filed against Intersect ENT Inc over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: XENT stocks, concerns whether certain Intersect ENT directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that the defendants failed to disclose to investors that the Company lacked adequate reimbursement representatives to ensure physicians had access to SINUVA, that, as a result, the Company's sales force would focus on ensuring reimbursement, that, as a result, the Company's sales representatives were less focused on driving sales, that physicians were less likely to adopt the Company's SINUVA due to transaction costs associated with seeking reimbursement, that the Company would increase staffing to address these issues, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Intersect ENT Inc (NASDAQ: XENT) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqxent-long-term-shareholder-notice-investigation-of-potential-wrongdoing-at-intersect-ent-inc-1249101.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com